[EN] IMIDAZOPYRIDINES AND IMIDAZOPYRIMIDINES AS HIV-I REVERSE TRANSCRIPTASE INHIBITORS<br/>[FR] IMIDAZOPYRIDINES ET IMIDAZOPYRIMIDINES UTILISÉS COMME INHIBITEURS DE LA TRANSCRIPTASE INVERSE DU VIH-1
申请人:CSIR
公开号:WO2010032195A1
公开(公告)日:2010-03-25
The invention provides compounds of formula A or B which are useful in the treatment of a subject infected with HIV.
这项发明提供了公式A或B的化合物,可用于治疗感染HIV的受试者。
IMIDAZOPYRIDINES AND IMIDAZOPYRIMIDINES AS HIV-I REVERSE TRANSCRIPTASE INHIBITORS
申请人:Bode Moira Leanne
公开号:US20110312957A1
公开(公告)日:2011-12-22
The invention provides compounds of formula A or B which are useful in the treatment of a subject infected with HIV.
本发明提供了公式A或B的化合物,其在治疗HIV感染的受试者中具有用处。
US8501767B2
申请人:——
公开号:US8501767B2
公开(公告)日:2013-08-06
Combretastatin A-4 inspired novel 2-aryl-3-arylamino-imidazo-pyridines/pyrazines as tubulin polymerization inhibitors, antimitotic and anticancer agents
作者:Nitesh Sanghai、Vaibhav Jain、Ranjan Preet、Somnath Kandekar、Sarita Das、Neha Trivedi、Purusottam Mohapatra、Garima Priyadarshani、Maneesh Kashyap、Dipon Das、Shakti Ranjan Satapathy、Sumit Siddharth、Sankar K. Guchhait、Chanakya N. Kundu、Prasad V. Bharatam
DOI:10.1039/c3md00357d
日期:——
Novel 2-aryl-3-arylamino-imidazo-pyridines/pyrazines that exhibit potent tubulin polymerization inhibition, anticancer activity, anti-migration of cancer cells, chromosomal damage, and apoptosis have been developed.